Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 62 (9), 1059-61

Further Evidence of Dopamine Transporter Dysregulation in ADHD: A Controlled PET Imaging Study Using Altropane

Affiliations

Further Evidence of Dopamine Transporter Dysregulation in ADHD: A Controlled PET Imaging Study Using Altropane

Thomas J Spencer et al. Biol Psychiatry.

Abstract

Background: The dopamine transporter (DAT) is known to be a key regulator of dopamine, and recent studies of genetics, treatment, and imaging have highlighted the role of DAT in attention-deficit/hyperactivity disorder (ADHD). The findings of in vivo neuroimaging of DAT in ADHD have been somewhat discrepant, however.

Method: Dopamine transporter binding was measured using a highly selective ligand (C-11 altropane) and positron emission tomography (PET). The sample consisted of 47 well-characterized, treatment-naïve, nonsmoking, non-comorbid adults with and without ADHD. Additionally, control subjects had few symptoms of ADHD.

Results: Results showed significantly increased DAT binding in the right caudate in adults with ADHD compared with matched control subjects without this disorder.

Conclusions: These results confirm abnormal DAT binding in the striatum of adults with ADHD and provide further support that dysregulation of DAT may be an important component of the pathophysiology of ADHD.

Similar articles

See all similar articles

Cited by 37 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

Substances

Feedback